Most progeria researchers focus on the genetic mutation that causes the disease, but a Houston Methodist team is targeting the shortening of telomeres.
A University of Missouri-led team developed a new gene transfer method to treat Duchenne muscular dystrophy.
Researchers have uncovered clues into how a genetic variant raises the risk of migraines, coronary artery disease and other related disorders.
PARP inhibitor Lynparza may be able to kill cancer cells that don’t have BRCA mutations—provided it’s paired with a helper compound.
The past week saw scientific advances in drug delivery, bladder cancer and the genetic underpinnings of depression.
A multipronged immune attack that includes CAR-T treatments may be needed to fight glioblastoma, Penn scientists suggest.
An international group of scientists is turning to a surprising ally in the quest to develop an HIV vaccine: the cow.
Feinstein Institute-led researchers used an Alzheimer’s drug to reduce inflammation in people with metabolic syndrome.
Targeting a cell process that promotes protein clumping could lead to new drugs for ALS.
This past week ushered in new discoveries in flu prevention, pancreatic cancer and HIV.